Feline Refractory Seizures: Diagnosis and Management

This article provides veterinarians with a structured approach to diagnosing and managing seizures in cats that do not respond to first-line antiepileptic drugs. Refractory seizures in cats require systematic investigation to identify underlying causes and implement appropriate treatment strategies while monitoring for adverse effects. The diagnostic workup for refractory seizures differs from initial seizure management because treatment failure raises suspicion for underlying structural, metabolic, or infectious causes.

At a Glance

Defining Refractory Seizures in Cats

Refractory epilepsy in cats is defined as continued seizure activity despite adequate trials of two or more appropriate antiepileptic drugs at therapeutic doses. The Merck Veterinary Manual notes that epilepsy is one of the most common neurologic conditions in cats, and a significant proportion of affected cats do not achieve adequate seizure control with first-line medications. The term refractory does not imply untreatable. Many cats with refractory seizures can achieve improved seizure control with adjusted medication protocols, alternative drug choices, or treatment of underlying conditions. The goal of management is to reduce seizure frequency and severity while minimizing adverse drug effects.

Diagnostic Workup for Refractory Seizures

History and Physical Examination

A thorough history is the foundation of the diagnostic workup. Document seizure onset, frequency, duration, and pattern. Note any changes in behavior, appetite, thirst, or elimination habits between seizures. Ask owners about potential toxin exposures, including permethrin-containing flea products, which are highly toxic to cats. Record all previous and current medications, including doses, durations, and response.

The physical examination should include a complete neurologic assessment. Look for interictal neurologic deficits such as circling, head pressing, visual deficits, or proprioceptive abnormalities. These findings suggest structural brain disease instead of primary epilepsy. Perform a fundic examination to check for retinal changes that may indicate underlying infectious or hypertensive disease.

Advanced Imaging

Magnetic resonance imaging (MRI) is the imaging modality of choice for evaluating cats with refractory seizures. MRI provides detailed visualization of brain structures and can identify neoplasia, inflammatory lesions, vascular anomalies, and congenital malformations. The Merck Veterinary Manual recommends MRI for cats with seizures that are difficult to control or when neurologic deficits are present between seizures.

Computed tomography (CT) is less sensitive for soft tissue detail but may be used when MRI is unavailable or contraindicated. CT is useful for detecting bony lesions, mineralized masses, or hemorrhage.

Cerebrospinal Fluid Analysis

CSF analysis should follow MRI when inflammatory or infectious causes are suspected. Collect CSF from the cerebellomedullary cistern under general anesthesia. Submit samples for cell count, protein concentration, and cytology. Additional testing may include culture, polymerase chain reaction for infectious agents, and antibody titers. CSF analysis is contraindicated in cats with elevated intracranial pressure due to risk of brain herniation. Evaluate MRI findings before proceeding with CSF collection.

Genetic Testing

Genetic testing is available for certain cat breeds with known epilepsy syndromes. The Journal of Feline Medicine and Surgery published a review of diagnostic workup for seizuring cats that discusses breed-related epilepsy. Testing may identify mutations associated with epilepsy in breeds such as the Maine Coon cat. Results can guide prognosis and breeding decisions.

Laboratory Evaluation

Perform baseline blood work including complete blood count, serum biochemistry profile, and thyroid hormone levels. These tests rule out metabolic causes of seizures such as hypoglycemia, hepatic encephalopathy, and hyperthyroidism. Measure bile acids if hepatic function is suspect. Check blood pressure to evaluate for hypertensive encephalopathy.

Medical Management of Refractory Seizures

Phenobarbital

Phenobarbital remains a first-line antiepileptic drug in cats. It is effective for many seizure types and is available in oral and injectable formulations. The Merck Veterinary Manual describes phenobarbital as a barbiturate that enhances GABA-mediated inhibition in the brain. Monitor serum phenobarbital concentrations to guide dosing. Therapeutic ranges are established for dogs but are less well defined in cats. Clinical response and adverse effects guide dose adjustments. Common adverse effects include sedation, ataxia, and polyphagia. Hepatotoxicity is less common in cats than in dogs but can occur with prolonged use or high doses.

Levetiracetam

Levetiracetam is a newer antiepileptic drug with a favorable safety profile in cats. It has a unique mechanism of action, binding to synaptic vesicle protein 2A. The drug is excreted primarily unchanged in urine, making it useful for cats with hepatic disease. Levetiracetam is available in immediate-release and extended-release formulations. The immediate-release form requires dosing three times daily due to its short half-life in cats. Extended-release formulations allow twice-daily dosing. Adverse effects are uncommon but may include sedation and gastrointestinal upset.

Zonisamide

Zonisamide is a sulfonamide antiepileptic drug used as an adjunctive treatment in cats. It blocks voltage-gated sodium channels and T-type calcium channels. The drug is metabolized in the liver and excreted in urine. Zonisamide can cause adverse effects including sedation, ataxia, and anorexia. Hepatotoxicity and hypersensitivity reactions are possible. Monitor liver enzymes periodically during therapy.

Potassium Bromide

Potassium bromide is used less frequently in cats than in dogs due to a higher risk of adverse effects. Cats have a long half-life for bromide, requiring careful dosing to avoid toxicity. The Merck Veterinary Manual notes that bromide can cause sedation, ataxia, and respiratory signs in cats. Potassium bromide is reserved for cats that fail other antiepileptic drugs. Monitor serum bromide concentrations to guide dosing. Adverse effects are more common at higher serum concentrations.

Gabapentin

Gabapentin is used as an adjunctive treatment for seizures in cats. A 2023 review in Animals discusses the clinical use and pharmacokinetics of gabapentin in cats. Gabapentin binds to the alpha-2-delta subunit of voltage-gated calcium channels, reducing neurotransmitter release. Gabapentin is well tolerated in cats. Adverse effects include sedation and ataxia, which are dose-dependent. The drug is excreted unchanged in urine, so dose adjustment may be needed in cats with renal disease.

Propofol for Status Epilepticus

Status epilepticus is a medical emergency requiring immediate intervention. Propofol is an injectable anesthetic used to control refractory seizures in cats. A case report in the Journal of Small Animal Practice describes propofol for treatment of refractory seizures in a cat with intracranial disorders. Propofol provides rapid seizure control but requires careful monitoring of respiratory and cardiovascular function. Use in a hospital setting with access to intubation and mechanical ventilation.

Monitoring for Adverse Effects

Clinical Monitoring

Monitor cats for adverse effects at each visit. Common adverse effects include sedation, ataxia, polyphagia, and gastrointestinal upset. Document the severity and duration of these effects. Adjust doses or change medications if adverse effects are unacceptable.

Laboratory Monitoring

Perform baseline blood work before starting antiepileptic drugs and repeat periodically during therapy. Monitor liver enzymes, kidney function, and serum drug concentrations as appropriate. The frequency of monitoring depends on the drug used and the individual cat's response.

Drug Interactions

Antiepileptic drugs can interact with each other and with other medications. Phenobarbital induces hepatic enzymes, potentially reducing the efficacy of other drugs metabolized by the liver. Levetiracetam has fewer drug interactions due to its renal excretion.

Common Failure Patterns

Inadequate Dosing

The most common cause of treatment failure is inadequate dosing. Ensure that cats receive the correct dose at the appropriate interval. Adjust doses based on clinical response and serum drug concentrations when available.

Poor Owner Compliance

Owner compliance is essential for successful seizure management. Educate owners about the importance of consistent medication administration. Discuss strategies for remembering doses and managing missed doses.

Progressive Underlying Disease

Seizures may become refractory due to progression of underlying brain disease. Repeat imaging and CSF analysis if seizure control deteriorates despite appropriate medication adjustments.

Drug Tolerance

Some cats develop tolerance to antiepileptic drugs over time. Dose adjustments or addition of a second drug may be needed to maintain seizure control.

Practical Implementation Steps

Step 1: Confirm the Diagnosis

Review the history and physical examination findings. Ensure that the events are truly seizures and not syncope, movement disorders, or behavioral events. Video recordings from owners can be helpful.

Step 2: Optimize Current Medications

Before adding new drugs, ensure that current medications are dosed appropriately. Check serum drug concentrations if available. Adjust doses to the upper end of the therapeutic range if adverse effects are acceptable.

Step 3: Add a Second Antiepileptic Drug

If seizure control remains inadequate, add a second drug with a different mechanism of action. Common combinations include phenobarbital with levetiracetam or zonisamide. Start the second drug at a low dose and titrate upward based on response and adverse effects.

Step 4: Consider Alternative Drugs

If the cat fails two or more drugs, consider alternative medications such as potassium bromide or gabapentin. Discuss the risks and benefits with the owner before starting these drugs.

Step 5: Reevaluate for Underlying Causes

If seizures remain refractory despite multiple drug trials, repeat the diagnostic workup. Consider advanced imaging, CSF analysis, and genetic testing if not already performed.

Records and Measurements

Maintain a seizure diary for each cat. Record the date, time, duration, and description of each seizure. Note any triggers, such as stress, excitement, or medication changes. Document postictal signs and recovery time. Track serum drug concentrations and laboratory values over time. Use this information to guide dose adjustments and monitor for adverse effects.

Quality and Welfare Controls

Seizures can negatively impact a cat's quality of life. Discuss the goals of therapy with owners. The aim is to reduce seizure frequency and severity while maintaining an acceptable quality of life. Some cats may continue to have occasional seizures despite optimal therapy. Monitor for adverse effects that affect welfare, such as excessive sedation, ataxia, or anorexia. Adjust medications to balance seizure control with adverse effects.

Limitations and Safety Context

The evidence base for antiepileptic drug use in cats is limited compared to dogs. Many drug doses are extrapolated from canine studies or based on small case series. Individual cats may respond differently to the same drug. Antiepileptic drugs can cause adverse effects that require dose adjustment or drug discontinuation. Monitor cats closely, especially when starting new medications or adjusting doses.

Professional Escalation Criteria

Refer cats to a veterinary neurologist if seizures remain refractory despite appropriate trials of two or more antiepileptic drugs. Neurologists can perform advanced diagnostics and offer additional treatment options such as continuous rate infusions or surgical intervention. Seek emergency care for cats in status epilepticus or with cluster seizures. These cats require immediate intervention to prevent brain damage and systemic complications.

Practical Decision Framework for Managing Refractory Seizures in Cats

A structured decision framework helps veterinarians navigate the complex process of managing cats with refractory seizures. Without a systematic approach, treatment decisions may become reactive instead of proactive, leading to prolonged seizure activity and unnecessary adverse effects. The framework presented here integrates diagnostic findings, medication adjustments, and monitoring protocols into a coherent clinical pathway. This approach draws on principles outlined in the Merck Veterinary Manual and the Journal of Feline Medicine and Surgery review of diagnostic workup for seizuring cats.

Tiered Treatment Algorithm

The tiered treatment algorithm organizes interventions based on seizure severity, frequency, and response to therapy. Tier 1 addresses cats with occasional breakthrough seizures despite adequate serum drug concentrations. Tier 2 covers cats with frequent seizures requiring medication adjustments. Tier 3 involves cats with cluster seizures or status epilepticus requiring emergency intervention.

Tier 1: Occasional Breakthrough Seizures

Cats in this tier experience one seizure every two to three months despite therapeutic serum drug concentrations. The first step is to confirm that the cat is receiving the correct dose at the appropriate interval. Check owner compliance by reviewing medication administration records. Ask owners about missed doses, delayed doses, or changes in administration routine. If compliance is adequate, consider a small dose increase of the current antiepileptic drug. Increase phenobarbital by 10 to 20 percent and recheck serum concentration in two to three weeks. For levetiracetam, increase the dose by 25 percent and monitor for sedation. Document the response over the next four to eight weeks before making further adjustments.

Tier 2: Frequent Seizures

Cats with more than one seizure per month or cluster seizures (two or more seizures within 24 hours) require more aggressive intervention. Start by optimizing the current drug regimen. Check serum drug concentrations for phenobarbital and potassium bromide. Adjust doses to achieve concentrations at the upper end of the therapeutic range if adverse effects are acceptable. If the cat is on monotherapy, add a second antiepileptic drug with a different mechanism of action. Common combinations include phenobarbital with levetiracetam or zonisamide. Start the second drug at a low dose and titrate upward over two to four weeks. Monitor for additive adverse effects such as sedation and ataxia. If the cat is already on two drugs, consider adding a third drug or switching to an alternative medication.

Tier 3: Cluster Seizures or Status Epilepticus

Cats with cluster seizures or status epilepticus require immediate veterinary intervention. Administer injectable diazepam or midazolam intravenously or rectally. If seizures continue, administer propofol as a bolus followed by a continuous rate infusion. A case report in the Journal of Small Animal Practice describes propofol for treatment of refractory seizures in a cat with intracranial disorders. Provide respiratory and cardiovascular support as needed. Once seizures are controlled, evaluate the cat for underlying causes and adjust the maintenance antiepileptic drug regimen. Consider hospitalization for continuous monitoring and intravenous fluid therapy.

Decision Points for Medication Changes

Medication changes should be based on specific decision points instead of arbitrary time intervals. The following decision points guide when to adjust, add, or switch medications.

Decision Point 1: Inadequate Response After Four Weeks

If a cat has not achieved a meaningful reduction in seizure frequency after four weeks of therapy at therapeutic serum drug concentrations, consider adding a second drug. Do not wait longer than eight weeks before making a change. Prolonged inadequate seizure control increases the risk of seizure-related brain damage and reduces quality of life.

Decision Point 2: Unacceptable Adverse Effects

If a cat develops adverse effects that affect quality of life, such as excessive sedation, ataxia, or anorexia, reduce the dose or switch to an alternative drug. Do not continue a medication at a dose that causes unacceptable adverse effects. The goal of therapy is to balance seizure control with adverse effects. Some adverse effects, such as mild sedation, may improve over time as the cat develops tolerance. Monitor for two to four weeks before making a final decision.

Decision Point 3: Deteriorating Seizure Control

If seizure frequency increases despite stable medication doses, reevaluate the cat for progressive underlying disease. Repeat the diagnostic workup including MRI and CSF analysis. Consider infectious causes such as toxoplasmosis or feline infectious peritonitis. Adjust medications based on the new diagnostic findings.

Decision Point 4: Drug Tolerance

Some cats develop tolerance to antiepileptic drugs over time. If a cat that was previously well controlled begins having breakthrough seizures, check serum drug concentrations. If concentrations are within the therapeutic range, consider adding a second drug instead of increasing the dose of the current drug. Increasing the dose may lead to adverse effects without improving seizure control.

Record System for Tracking Seizure Activity and Medication Adjustments

A standardized record system is essential for managing cats with refractory seizures. The record system should include a seizure diary, medication log, and laboratory monitoring sheet.

Seizure Diary

The seizure diary should be maintained by the owner and reviewed at each visit. Record the following information for each seizure:

• Date and time of seizure
• Duration of seizure activity
• Description of seizure type (generalized, focal, or complex partial)
• Postictal signs and duration
• Any potential triggers (stress, excitement, medication changes, environmental changes)
• Number of seizures in a 24-hour period (cluster seizures)

Provide owners with a printed seizure diary template or direct them to a mobile app designed for tracking pet seizures. Review the diary at each visit and calculate the seizure frequency per month. Use this information to guide medication adjustments.

Medication Log

The medication log should document all antiepileptic drugs, doses, administration times, and any changes. Record the following information:

• Drug name and formulation (immediate-release or extended-release)
• Dose in milligrams per kilogram
• Administration interval
• Date of dose changes
• Reason for dose changes (inadequate response, adverse effects, or laboratory findings)
• Serum drug concentrations and date of measurement

Maintain the medication log in the medical record and update it at each visit. Use the log to identify patterns of inadequate dosing or poor compliance.

Laboratory Monitoring Sheet

The laboratory monitoring sheet should track serum drug concentrations, liver enzymes, kidney function, and other relevant parameters. Record the following information:

• Date of blood collection
• Serum phenobarbital concentration
• Serum potassium bromide concentration (if applicable)
• Alanine aminotransferase (ALT) and alkaline phosphatase (ALP) for liver monitoring
• Creatinine and blood urea nitrogen for kidney monitoring
• Total protein and albumin
• Thyroid hormone levels (if indicated)

Plot serum drug concentrations over time to identify trends. Use this information to adjust doses and monitor for toxicity.

Troubleshooting Method for Common Clinical Scenarios

The troubleshooting method provides a systematic approach to common clinical scenarios encountered in managing cats with refractory seizures.

Scenario 1: Cat Continues to Seize Despite Therapeutic Phenobarbital Concentration

If a cat has a serum phenobarbital concentration within the therapeutic range (typically 15 to 45 micrograms per milliliter in dogs, with less well-defined ranges in cats) but continues to seize, consider the following steps:

1. Confirm that the serum concentration was measured at trough (immediately before the next dose).
2. Check for drug interactions that may reduce phenobarbital efficacy.
3. Add a second antiepileptic drug such as levetiracetam or zonisamide.
4. Consider alternative diagnoses such as structural brain disease or metabolic disorders.
5. Repeat MRI and CSF analysis if not already performed.

Scenario 2: Cat Develops Severe Sedation After Starting Levetiracetam

If a cat develops excessive sedation after starting levetiracetam, consider the following steps:

1. Reduce the levetiracetam dose by 25 to 50 percent.
2. If sedation persists, switch to the extended-release formulation, which may cause less sedation due to more stable serum concentrations.
3. If sedation continues despite dose reduction, discontinue levetiracetam and try an alternative drug such as zonisamide.
4. Monitor for other causes of sedation such as hepatic encephalopathy or electrolyte imbalances.

Scenario 3: Cat Develops Anorexia and Weight Loss on Zonisamide

If a cat develops anorexia and weight loss after starting zonisamide, consider the following steps:

1. Reduce the zonisamide dose by 25 percent.
2. If anorexia persists, discontinue zonisamide and try an alternative drug.
3. Monitor liver enzymes to rule out hepatotoxicity.
4. Provide nutritional support with appetite stimulants or assisted feeding if needed.

Scenario 4: Cat Has Breakthrough Seizures After Years of Good Control

If a cat that was well controlled for years begins having breakthrough seizures, consider the following steps:

1. Check serum drug concentrations to rule out subtherapeutic levels due to changes in metabolism or compliance.
2. Repeat the diagnostic workup including MRI and CSF analysis to evaluate for progressive underlying disease.
3. Consider adding a second antiepileptic drug instead of increasing the dose of the current drug.
4. Evaluate for new metabolic disorders such as hyperthyroidism or hepatic disease.

Comparison of Second-Line Antiepileptic Drugs

The choice of second-line antiepileptic drug depends on the individual cat's response, adverse effect profile, and underlying cause of seizures. The following comparison helps guide drug selection.

Levetiracetam versus Zonisamide

Levetiracetam has a favorable safety profile with minimal drug interactions. It is excreted primarily unchanged in urine, making it useful for cats with hepatic disease. The main disadvantage is the need for three times daily dosing with the immediate-release formulation. Extended-release formulations allow twice-daily dosing but may be less readily available. Adverse effects are uncommon but may include sedation and gastrointestinal upset.

Zonisamide is a sulfonamide antiepileptic drug that blocks voltage-gated sodium channels and T-type calcium channels. It is metabolized in the liver and excreted in urine. Zonisamide can cause adverse effects including sedation, ataxia, and anorexia. Hepatotoxicity and hypersensitivity reactions are possible. Monitor liver enzymes periodically during therapy. Zonisamide may be preferred when once or twice daily dosing is desired.

Potassium Bromide versus Gabapentin

Potassium bromide is used less frequently in cats than in dogs due to a higher risk of adverse effects. Cats have a long half-life for bromide, requiring careful dosing to avoid toxicity. The Merck Veterinary Manual notes that bromide can cause sedation, ataxia, and respiratory signs in cats. Potassium bromide is reserved for cats that fail other antiepileptic drugs. Monitor serum bromide concentrations to guide dosing. Adverse effects are more common at higher serum concentrations.

Gabapentin is used as an adjunctive treatment for seizures in cats. A 2023 review in Animals discusses the clinical use and pharmacokinetics of gabapentin in cats. Gabapentin binds to the alpha-2-delta subunit of voltage-gated calcium channels, reducing neurotransmitter release. Gabapentin is well tolerated in cats. Adverse effects include sedation and ataxia, which are dose-dependent. The drug is excreted unchanged in urine, so dose adjustment may be needed in cats with renal disease. Gabapentin may be preferred when a drug with minimal hepatic metabolism is needed.

Implementation Steps for the Decision Framework

Implement the decision framework in clinical practice using the following steps:

Step 1: Classify the Cat into a Tier

Based on seizure frequency and severity, classify the cat into Tier 1, 2, or 3. Use the tier to guide the initial intervention.

Step 2: Review the Record System

Review the seizure diary, medication log, and laboratory monitoring sheet. Identify patterns of inadequate dosing, poor compliance, or progressive disease.

Step 3: Apply the Troubleshooting Method

Use the troubleshooting method to address specific clinical scenarios. Follow the steps outlined for each scenario.

Step 4: Select a Second-Line Drug

Based on the comparison of second-line antiepileptic drugs, select the most appropriate drug for the individual cat. Consider the cat's hepatic and renal function, adverse effect profile, and owner preferences.

Step 5: Monitor and Adjust

Monitor the cat's response over the next four to eight weeks. Adjust doses or switch drugs as needed. Repeat the diagnostic workup if seizure control deteriorates.

Common Failure Patterns in the Decision Framework

The decision framework may fail if certain patterns are not recognized. Common failure patterns include:

Pattern 1: Inadequate Diagnostic Workup

If the underlying cause of seizures is not identified, treatment may be ineffective. Ensure that all cats with refractory seizures undergo MRI and CSF analysis. Repeat the diagnostic workup if seizure control deteriorates.

Pattern 2: Inadequate Dose Titration

Some cats require higher doses of antiepileptic drugs than standard recommendations. Titrate doses based on clinical response and serum drug concentrations. Do not stop at the lower end of the therapeutic range if the cat continues to seize.

Pattern 3: Poor Owner Compliance

Owner compliance is essential for successful seizure management. Educate owners about the importance of consistent medication administration. Discuss strategies for remembering doses and managing missed doses. Consider using pill organizers or mobile reminders.

Pattern 4: Drug Interactions

Antiepileptic drugs can interact with each other and with other medications. Phenobarbital induces hepatic enzymes, potentially reducing the efficacy of other drugs metabolized by the liver. Levetiracetam has fewer drug interactions due to its renal excretion. Monitor for drug interactions when adding or removing medications.

Quality and Welfare Considerations

The decision framework prioritizes quality of life for both the cat and the owner. Seizures can negatively impact a cat's quality of life, but so can adverse effects of medications. Discuss the goals of therapy with owners. The aim is to reduce seizure frequency and severity while maintaining an acceptable quality of life. Some cats may continue to have occasional seizures despite optimal therapy. Monitor for adverse effects that affect welfare, such as excessive sedation, ataxia, or anorexia. Adjust medications to balance seizure control with adverse effects.

Limitations and Safety Context

The decision framework is based on current evidence and clinical experience. However, the evidence base for antiepileptic drug use in cats is limited compared to dogs. Many drug doses are extrapolated from canine studies or based on small case series. Individual cats may respond differently to the same drug. Antiepileptic drugs can cause adverse effects that require dose adjustment or drug discontinuation. Monitor cats closely, especially when starting new medications or adjusting doses.

Professional Escalation Criteria

Refer cats to a veterinary neurologist if seizures remain refractory despite appropriate trials of two or more antiepileptic drugs. Neurologists can perform advanced diagnostics and offer additional treatment options such as continuous rate infusions or surgical intervention. Seek emergency care for cats in status epilepticus or with cluster seizures. These cats require immediate intervention to prevent brain damage and systemic complications.

Practical Decision Framework for Managing Refractory Seizures in Cats

A structured decision framework helps veterinarians navigate the complex process of managing cats with refractory seizures. Without a systematic approach, treatment decisions may become reactive instead of proactive, leading to prolonged seizure activity and unnecessary adverse effects. The framework presented here integrates diagnostic findings, medication adjustments, and monitoring protocols into a coherent clinical pathway. This approach draws on principles outlined in the Merck Veterinary Manual and the Journal of Feline Medicine and Surgery review of diagnostic workup for seizuring cats.

Tiered Treatment Algorithm

The tiered treatment algorithm organizes interventions based on seizure severity, frequency, and response to therapy. Tier 1 addresses cats with occasional breakthrough seizures despite adequate serum drug concentrations. Tier 2 covers cats with frequent seizures requiring medication adjustments. Tier 3 involves cats with cluster seizures or status epilepticus requiring emergency intervention.

Tier 1: Occasional Breakthrough Seizures

Cats in this tier experience one seizure every two to three months despite therapeutic serum drug concentrations. The first step is to confirm that the cat is receiving the correct dose at the appropriate interval. Check owner compliance by reviewing medication administration records. Ask owners about missed doses, delayed doses, or changes in administration routine. If compliance is adequate, consider a small dose increase of the current antiepileptic drug. Increase phenobarbital by 10 to 20 percent and recheck serum concentration in two to three weeks. For levetiracetam, increase the dose by 25 percent and monitor for sedation. Document the response over the next four to eight weeks before making further adjustments.

Tier 2: Frequent Seizures

Cats with more than one seizure per month or cluster seizures (two or more seizures within 24 hours) require more aggressive intervention. Start by optimizing the current drug regimen. Check serum drug concentrations for phenobarbital and potassium bromide. Adjust doses to achieve concentrations at the upper end of the therapeutic range if adverse effects are acceptable. If the cat is on monotherapy, add a second antiepileptic drug with a different mechanism of action. Common combinations include phenobarbital with levetiracetam or zonisamide. Start the second drug at a low dose and titrate upward over two to four weeks. Monitor for additive adverse effects such as sedation and ataxia. If the cat is already on two drugs, consider adding a third drug or switching to an alternative medication.

Tier 3: Cluster Seizures or Status Epilepticus

Cats with cluster seizures or status epilepticus require immediate veterinary intervention. Administer injectable diazepam or midazolam intravenously or rectally. If seizures continue, administer propofol as a bolus followed by a continuous rate infusion. A case report in the Journal of Small Animal Practice describes propofol for treatment of refractory seizures in a cat with intracranial disorders. Provide respiratory and cardiovascular support as needed. Once seizures are controlled, evaluate the cat for underlying causes and adjust the maintenance antiepileptic drug regimen. Consider hospitalization for continuous monitoring and intravenous fluid therapy.

Decision Points for Medication Changes

Medication changes should be based on specific decision points instead of arbitrary time intervals. The following decision points guide when to adjust, add, or switch medications.

Decision Point 1: Inadequate Response After Four Weeks

If a cat has not achieved a meaningful reduction in seizure frequency after four weeks of therapy at therapeutic serum drug concentrations, consider adding a second drug. Do not wait longer than eight weeks before making a change. Prolonged inadequate seizure control increases the risk of seizure-related brain damage and reduces quality of life.

Decision Point 2: Unacceptable Adverse Effects

If a cat develops adverse effects that affect quality of life, such as excessive sedation, ataxia, or anorexia, reduce the dose or switch to an alternative drug. Do not continue a medication at a dose that causes unacceptable adverse effects. The goal of therapy is to balance seizure control with adverse effects. Some adverse effects, such as mild sedation, may improve over time as the cat develops tolerance. Monitor for two to four weeks before making a final decision.

Decision Point 3: Deteriorating Seizure Control

If seizure frequency increases despite stable medication doses, reevaluate the cat for progressive underlying disease. Repeat the diagnostic workup including MRI and CSF analysis. Consider infectious causes such as toxoplasmosis or feline infectious peritonitis. Adjust medications based on the new diagnostic findings.

Decision Point 4: Drug Tolerance

Some cats develop tolerance to antiepileptic drugs over time. If a cat that was previously well controlled begins having breakthrough seizures, check serum drug concentrations. If concentrations are within the therapeutic range, consider adding a second drug instead of increasing the dose of the current drug. Increasing the dose may lead to adverse effects without improving seizure control.

Record System for Tracking Seizure Activity and Medication Adjustments

A standardized record system is essential for managing cats with refractory seizures. The record system should include a seizure diary, medication log, and laboratory monitoring sheet.

Seizure Diary

The seizure diary should be maintained by the owner and reviewed at each visit. Record the following information for each seizure:

• Date and time of seizure
• Duration of seizure activity
• Description of seizure type (generalized, focal, or complex partial)
• Postictal signs and duration
• Any potential triggers (stress, excitement, medication changes, environmental changes)
• Number of seizures in a 24-hour period (cluster seizures)

Provide owners with a printed seizure diary template or direct them to a mobile app designed for tracking pet seizures. Review the diary at each visit and calculate the seizure frequency per month. Use this information to guide medication adjustments.

Medication Log

The medication log should document all antiepileptic drugs, doses, administration times, and any changes. Record the following information:

• Drug name and formulation (immediate-release or extended-release)
• Dose in milligrams per kilogram
• Administration interval
• Date of dose changes
• Reason for dose changes (inadequate response, adverse effects, or laboratory findings)
• Serum drug concentrations and date of measurement

Maintain the medication log in the medical record and update it at each visit. Use the log to identify patterns of inadequate dosing or poor compliance.

Laboratory Monitoring Sheet

The laboratory monitoring sheet should track serum drug concentrations, liver enzymes, kidney function, and other relevant parameters. Record the following information:

• Date of blood collection
• Serum phenobarbital concentration
• Serum potassium bromide concentration (if applicable)
• Alanine aminotransferase (ALT) and alkaline phosphatase (ALP) for liver monitoring
• Creatinine and blood urea nitrogen for kidney monitoring
• Total protein and albumin
• Thyroid hormone levels (if indicated)

Plot serum drug concentrations over time to identify trends. Use this information to adjust doses and monitor for toxicity.

Troubleshooting Method for Common Clinical Scenarios

The troubleshooting method provides a systematic approach to common clinical scenarios encountered in managing cats with refractory seizures.

Scenario 1: Cat Continues to Seize Despite Therapeutic Phenobarbital Concentration

If a cat has a serum phenobarbital concentration within the therapeutic range (typically 15 to 45 micrograms per milliliter in dogs, with less well-defined ranges in cats) but continues to seize, consider the following steps:

1. Confirm that the serum concentration was measured at trough (immediately before the next dose).
2. Check for drug interactions that may reduce phenobarbital efficacy.
3. Add a second antiepileptic drug such as levetiracetam or zonisamide.
4. Consider alternative diagnoses such as structural brain disease or metabolic disorders.
5. Repeat MRI and CSF analysis if not already performed.

Scenario 2: Cat Develops Severe Sedation After Starting Levetiracetam

If a cat develops excessive sedation after starting levetiracetam, consider the following steps:

1. Reduce the levetiracetam dose by 25 to 50 percent.
2. If sedation persists, switch to the extended-release formulation, which may cause less sedation due to more stable serum concentrations.
3. If sedation continues despite dose reduction, discontinue levetiracetam and try an alternative drug such as zonisamide.
4. Monitor for other causes of sedation such as hepatic encephalopathy or electrolyte imbalances.

Scenario 3: Cat Develops Anorexia and Weight Loss on Zonisamide

If a cat develops anorexia and weight loss after starting zonisamide, consider the following steps:

1. Reduce the zonisamide dose by 25 percent.
2. If anorexia persists, discontinue zonisamide and try an alternative drug.
3. Monitor liver enzymes to rule out hepatotoxicity.
4. Provide nutritional support with appetite stimulants or assisted feeding if needed.

Scenario 4: Cat Has Breakthrough Seizures After Years of Good Control

If a cat that was well controlled for years begins having breakthrough seizures, consider the following steps:

1. Check serum drug concentrations to rule out subtherapeutic levels due to changes in metabolism or compliance.
2. Repeat the diagnostic workup including MRI and CSF analysis to evaluate for progressive underlying disease.
3. Consider adding a second antiepileptic drug instead of increasing the dose of the current drug.
4. Evaluate for new metabolic disorders such as hyperthyroidism or hepatic disease.

Comparison of Second-Line Antiepileptic Drugs

The choice of second-line antiepileptic drug depends on the individual cat's response, adverse effect profile, and underlying cause of seizures. The following comparison helps guide drug selection.

Levetiracetam versus Zonisamide

Levetiracetam has a favorable safety profile with minimal drug interactions. It is excreted primarily unchanged in urine, making it useful for cats with hepatic disease. The main disadvantage is the need for three times daily dosing with the immediate-release formulation. Extended-release formulations allow twice-daily dosing but may be less readily available. Adverse effects are uncommon but may include sedation and gastrointestinal upset.

Zonisamide is a sulfonamide antiepileptic drug that blocks voltage-gated sodium channels and T-type calcium channels. It is metabolized in the liver and excreted in urine. Zonisamide can cause adverse effects including sedation, ataxia, and anorexia. Hepatotoxicity and hypersensitivity reactions are possible. Monitor liver enzymes periodically during therapy. Zonisamide may be preferred when once or twice daily dosing is desired.

Potassium Bromide versus Gabapentin

Potassium bromide is used less frequently in cats than in dogs due to a higher risk of adverse effects. Cats have a long half-life for bromide, requiring careful dosing to avoid toxicity. The Merck Veterinary Manual notes that bromide can cause sedation, ataxia, and respiratory signs in cats. Potassium bromide is reserved for cats that fail other antiepileptic drugs. Monitor serum bromide concentrations to guide dosing. Adverse effects are more common at higher serum concentrations.

Gabapentin is used as an adjunctive treatment for seizures in cats. A 2023 review in Animals discusses the clinical use and pharmacokinetics of gabapentin in cats. Gabapentin binds to the alpha-2-delta subunit of voltage-gated calcium channels, reducing neurotransmitter release. Gabapentin is well tolerated in cats. Adverse effects include sedation and ataxia, which are dose-dependent. The drug is excreted unchanged in urine, so dose adjustment may be needed in cats with renal disease. Gabapentin may be preferred when a drug with minimal hepatic metabolism is needed.

Implementation Steps for the Decision Framework

Implement the decision framework in clinical practice using the following steps:

Step 1: Classify the Cat into a Tier

Based on seizure frequency and severity, classify the cat into Tier 1, 2, or 3. Use the tier to guide the initial intervention.

Step 2: Review the Record System

Review the seizure diary, medication log, and laboratory monitoring sheet. Identify patterns of inadequate dosing, poor compliance, or progressive disease.

Step 3: Apply the Troubleshooting Method

Use the troubleshooting method to address specific clinical scenarios. Follow the steps outlined for each scenario.

Step 4: Select a Second-Line Drug

Based on the comparison of second-line antiepileptic drugs, select the most appropriate drug for the individual cat. Consider the cat's hepatic and renal function, adverse effect profile, and owner preferences.

Step 5: Monitor and Adjust

Monitor the cat's response over the next four to eight weeks. Adjust doses or switch drugs as needed. Repeat the diagnostic workup if seizure control deteriorates.

Common Failure Patterns in the Decision Framework

The decision framework may fail if certain patterns are not recognized. Common failure patterns include:

Pattern 1: Inadequate Diagnostic Workup

If the underlying cause of seizures is not identified, treatment may be ineffective. Ensure that all cats with refractory seizures undergo MRI and CSF analysis. Repeat the diagnostic workup if seizure control deteriorates.

Pattern 2: Inadequate Dose Titration

Some cats require higher doses of antiepileptic drugs than standard recommendations. Titrate doses based on clinical response and serum drug concentrations. Do not stop at the lower end of the therapeutic range if the cat continues to seize.

Pattern 3: Poor Owner Compliance

Owner compliance is essential for successful seizure management. Educate owners about the importance of consistent medication administration. Discuss strategies for remembering doses and managing missed doses. Consider using pill organizers or mobile reminders.

Pattern 4: Drug Interactions

Antiepileptic drugs can interact with each other and with other medications. Phenobarbital induces hepatic enzymes, potentially reducing the efficacy of other drugs metabolized by the liver. Levetiracetam has fewer drug interactions due to its renal excretion. Monitor for drug interactions when adding or removing medications.

Quality and Welfare Considerations

The decision framework prioritizes quality of life for both the cat and the owner. Seizures can negatively impact a cat's quality of life, but so can adverse effects of medications. Discuss the goals of therapy with owners. The aim is to reduce seizure frequency and severity while maintaining an acceptable quality of life. Some cats may continue to have occasional seizures despite optimal therapy. Monitor for adverse effects that affect welfare, such as excessive sedation, ataxia, or anorexia. Adjust medications to balance seizure control with adverse effects.

Limitations and Safety Context

The decision framework is based on current evidence and clinical experience. However, the evidence base for antiepileptic drug use in cats is limited compared to dogs. Many drug doses are extrapolated from canine studies or based on small case series. Individual cats may respond differently to the same drug. Antiepileptic drugs can cause adverse effects that require dose adjustment or drug discontinuation. Monitor cats closely, especially when starting new medications or adjusting doses.

Professional Escalation Criteria

Refer cats to a veterinary neurologist if seizures remain refractory despite appropriate trials of two or more antiepileptic drugs. Neurologists can perform advanced diagnostics and offer additional treatment options such as continuous rate infusions or surgical intervention. Seek emergency care for cats in status epilepticus or with cluster seizures. These cats require immediate intervention to prevent brain damage and systemic complications.

Frequently Asked Questions

What defines refractory seizures in cats?

Refractory seizures are defined as continued seizure activity despite adequate trials of two or more appropriate antiepileptic drugs at therapeutic doses. The Merck Veterinary Manual notes that a significant proportion of cats with epilepsy do not achieve adequate seizure control with first-line medications.

What diagnostic tests are recommended for cats with refractory seizures?

Recommended diagnostic tests include MRI of the brain, CSF analysis, genetic testing for breed-related epilepsy, and baseline blood work to rule out metabolic causes. The Journal of Feline Medicine and Surgery published a review discussing the diagnostic workup for seizuring cats.

Which antiepileptic drugs are used for refractory seizures in cats?

Commonly used drugs include phenobarbital, levetiracetam, zonisamide, potassium bromide, and gabapentin. The choice depends on the individual cat's response, adverse effects, and underlying cause of seizures.

How do I monitor for adverse effects of antiepileptic drugs in cats?

Monitor for clinical signs such as sedation, ataxia, polyphagia, and gastrointestinal upset. Perform periodic blood work to check liver enzymes, kidney function, and serum drug concentrations. Adjust doses based on response and adverse effects.

What should I do if a cat has status epilepticus?

Status epilepticus is a medical emergency. Administer injectable antiepileptic drugs such as diazepam or propofol. A case report in the Journal of Small Animal Practice describes propofol for treatment of refractory seizures in a cat with intracranial disorders. Provide respiratory and cardiovascular support as needed.

Can genetic testing help manage refractory seizures in cats?

Genetic testing can identify breed-related epilepsy syndromes, which may guide prognosis and breeding decisions. Testing is available for certain breeds such as the Maine Coon cat.

When should I refer a cat to a veterinary neurologist?

Refer cats that remain refractory despite appropriate trials of two or more antiepileptic drugs. Neurologists can perform advanced diagnostics and offer additional treatment options.

What is the prognosis for cats with refractory seizures?

The prognosis depends on the underlying cause. Cats with primary epilepsy may achieve good seizure control with appropriate medication adjustments. Cats with structural brain disease may have a guarded prognosis depending on the specific lesion.

Related Veterinary Guides

• Cat
• Hypertrophic Cardiomyopathy In Cats
• Prescription Medicine For Cats
• Sneezing Cat Remedy
• Cat Tapeworm Medicine

References and Further Reading

• www.merckvetmanual.com
• catvets.com
• www.acvim.org
• Merck Veterinary Manual. Merck Veterinary Manual.
• Animal Health and Welfare. World Organisation for Animal Health.
• Gabapentin: Clinical Use and Pharmacokinetics in Dogs, Cats, and Horses.. Animals : an open access journal from MDPI, 2023.
• Propofol for treatment of refractory seizures in dogs and a cat with intracranial disorders.. The Journal of small animal practice, 2000.
• Management of refractory epilepsy.. Topics in companion animal medicine, 2013.
• Epileptogenesis and companion animals.. Topics in companion animal medicine, 2013.
• Lycanthropy and self-identification.. The Journal of nervous and mental disease, 1990.
• The seizuring cat. Diagnostic work-up and therapy.. Journal of feline medicine and surgery, 2009.
• Clinical signs, aetiology and outcome in 30 cats with recurrent seizures (2002-2018). Journal of the Hellenic Veterinary Medical Society, 2020.

This article is educational and is not a substitute for veterinary diagnosis or treatment. Contact a veterinarian for advice about an individual animal.